Literature DB >> 18596090

Functional analysis of the complex trans-activating response element RNA structure in simian immunodeficiency virus.

Mireille Centlivre1, Bep Klaver, Ben Berkhout, Atze T Das.   

Abstract

Transcription of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) is activated through binding of the viral Tat protein to the trans-activating response (TAR) element at the 5' end of the nascent transcript. Whereas HIV type 1 (HIV-1) TAR folds a simple hairpin structure, the corresponding domains of HIV-2 and SIVmac exhibit a more complex structure composed of three stem-loops. This structural polymorphism may be attributed to additional functions of TAR in HIV-2/SIVmac replication. We recently constructed an SIVmac variant that does not require the Tat-TAR interaction for transcription. We used this variant to study additional roles of TAR in SIVmac replication and generated mutants with a truncated TAR structure. We demonstrate that partial or nearly complete removal of TAR does not impair viral transcription, RNA processing, and translation. Moreover, these deletions do not significantly affect virus replication in the PM1 T-cell line and macaque peripheral blood mononuclear cells. These results demonstrate that the complex TAR structure in SIVmac has no other essential function in virus replication in vitro besides its role in Tat-mediated activation of transcription.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18596090      PMCID: PMC2546907          DOI: 10.1128/JVI.00530-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Multiple biological roles associated with the repeat (R) region of the HIV-1 RNA genome.

Authors:  B Berkhout
Journal:  Adv Pharmacol       Date:  2000

2.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.

Authors:  A I Dayton; J G Sodroski; C A Rosen; W C Goh; W A Haseltine
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  Tat trans-activates the human immunodeficiency virus through a nascent RNA target.

Authors:  B Berkhout; R H Silverman; K T Jeang
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

4.  Genome organization and transactivation of the human immunodeficiency virus type 2.

Authors:  M Guyader; M Emerman; P Sonigo; F Clavel; L Montagnier; M Alizon
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

5.  New human and simian HIV-related retroviruses possess functional transactivator (tat) gene.

Authors:  S K Arya; B Beaver; L Jagodzinski; B Ensoli; P J Kanki; J Albert; E M Fenyo; G Biberfeld; J F Zagury; F Laure
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

6.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

Authors:  B R Cullen
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

7.  Viral evolution as a tool to improve the tetracycline-regulated gene expression system.

Authors:  Atze T Das; Xue Zhou; Monique Vink; Bep Klaver; Koen Verhoef; Giuseppe Marzio; Ben Berkhout
Journal:  J Biol Chem       Date:  2004-02-02       Impact factor: 5.157

8.  A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions.

Authors:  Marcel Ooms; Hendrik Huthoff; Rodney Russell; Chen Liang; Ben Berkhout
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

Authors:  S K Arya; C Guo; S F Josephs; F Wong-Staal
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

10.  The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1.

Authors:  M Emerman; M Guyader; L Montagnier; D Baltimore; M A Muesing
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  8 in total

1.  A doxycycline-dependent human immunodeficiency virus type 1 replicates in vivo without inducing CD4+ T-cell depletion.

Authors:  Nicolas Legrand; Gisela J van der Velden; Raphaël Ho Tsong Fang; Marc Douaisi; Kees Weijer; Atze T Das; Bianca Blom; Christel H Uittenbogaart; Ben Berkhout; Mireille Centlivre
Journal:  J Gen Virol       Date:  2012-05-30       Impact factor: 3.891

2.  Regulation of SIV mac 239 basal long terminal repeat activity and viral replication in macrophages: functional roles of two CCAAT/enhancer-binding protein beta sites in activation and interferon beta-mediated suppression.

Authors:  Shruthi Ravimohan; Lucio Gama; Sheila A Barber; Janice E Clements
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

3.  Silencing integrated SIV proviral DNA with TAR-specific CRISPR tools.

Authors:  Lisa M Smith; Vida L Hodara; Laura M Parodi; Jessica E Callery; Luis D Giavedoni
Journal:  J Med Primatol       Date:  2020-09-09       Impact factor: 0.667

4.  Simian immunodeficiency virus transiently increases brain temperature in rhesus monkeys: detection with magnetic resonance spectroscopy thermometry.

Authors:  Dionyssios Mintzopoulos; Eva-Maria Ratai; Julian He; Ramon Gilberto Gonzalez; Marc J Kaufman
Journal:  Magn Reson Med       Date:  2019-01-16       Impact factor: 4.668

5.  ShapeSorter: a fully probabilistic method for detecting conserved RNA structure features supported by SHAPE evidence.

Authors:  Volodymyr Tsybulskyi; Irmtraud M Meyer
Journal:  Nucleic Acids Res       Date:  2022-08-26       Impact factor: 19.160

6.  Opening of the TAR hairpin in the HIV-1 genome causes aberrant RNA dimerization and packaging.

Authors:  Atze T Das; Martine M Vrolijk; Alex Harwig; Ben Berkhout
Journal:  Retrovirology       Date:  2012-07-24       Impact factor: 4.602

7.  Different effects of the TAR structure on HIV-1 and HIV-2 genomic RNA translation.

Authors:  Ricardo Soto-Rifo; Taran Limousin; Paulina S Rubilar; Emiliano P Ricci; Didier Décimo; Olivier Moncorgé; Mary-Anne Trabaud; Patrice André; Andrea Cimarelli; Théophile Ohlmann
Journal:  Nucleic Acids Res       Date:  2011-11-24       Impact factor: 16.971

8.  The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation.

Authors:  Sonia Mediouni; Cari F Kessing; Joseph A Jablonski; Suzie Thenin-Houssier; Mark Clementz; Melia D Kovach; Guillaume Mousseau; Ian Mitchelle S de Vera; Chuan Li; Douglas J Kojetin; David T Evans; Susana T Valente
Journal:  FASEB J       Date:  2019-04-25       Impact factor: 5.834

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.